Melioidosis in Malaysia

Medical Journal of Malaysia

Volumn 64, Issue 4, 2009, Pages 266-274

  Puthucheary, Savithiri D ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Burkholderia pseudomallei; Malaysia; Melioidosis

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CARBAPENEM; CEFTAZIDIME; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INSULIN; MACROLIDE; MEROPENEM; NITRIC OXIDE; PENICILLIN G; QUINOLONE DERIVATIVE; RIFAMYCIN; RUTHENIUM; TETRACYCLINE; TRIMETHOPRIM;

ADULT RESPIRATORY DISTRESS SYNDROME; ALCOHOLISM; ALLIGATOR; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; AUSTRALIA; BACTEREMIA; BACTERIUM CULTURE; BACTERIUM ISOLATION; BUFFALO; BURKHOLDERIA PSEUDOMALLEI; CAMEL; CHINESE; CONTINUOUS INFUSION; DEER; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; DRUG ABUSE; DRUG RESPONSE; ECOLOGY; ERADICATION THERAPY; ETHNICITY; FOLLOW UP; HAMSTER; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INCUBATION TIME; INDIAN; INFECTION; INFLAMMATION; INGESTION; INHALATION; INJURY; INOCULATION; KANGAROO; KIDNEY FAILURE; LUNG DISEASE; LUNG INFECTION; LUNG INFILTRATE; MAINTENANCE THERAPY; MALAYSIA; MELIOIDOSIS; MINIMUM INHIBITORY CONCENTRATION; MONKEY; MONOTHERAPY; MORBIDITY; MORTALITY; NEOPLASM; NEPHROLITHIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OCCUPATIONAL EXPOSURE; ORANG UTAN; PARROT; PATHOGENESIS; PATIENT COMPLIANCE; PATIENT MONITORING; PNEUMONIA; PURCHASING; RADIOGRAPHY; RECURRENT DISEASE; RELAPSE; RETROVIRUS INFECTION; REVIEW; SEPSIS; SEPTICEMIA; SEROLOGY; SHEEP; SINGAPORE; SOFT TISSUE INFECTION; SOUTHEAST ASIA; SPLENECTOMY; STEROID THERAPY; THAILAND; VIRULENCE; WOUND CARE; WOUND DRESSING; ZEBRA FISH; COMPLICATION; ISOLATION AND PURIFICATION; RISK FACTOR;

BURKHOLDERIA PSEUDOMALLEI; ECOLOGY; HUMANS; MALAYSIA; MELIOIDOSIS; RECURRENCE; RISK FACTORS;

EID: 77958042504     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Whitmore A, Krishnaswami CS. An account of the discovery of a hitherto undiscovered infective disease occurring among the population of Rangoon. Indian Med Gaz 1912; 47: 262-7.
2. Stanton AT, Fletcher W. Melioidosis. Studies from the Institute for Medical Research, Federated Malay States, John Bale and Sons and Danielson Ltd, London, 1932; 21.
3. Melioidosis in Animals. Technical report number 15, Department of Veterinary Services, Ministry of Agriculture, Malaysia.
4. Thin RNT, Brown M, Srewart JB, Garrett CJ. Melioidosis: A report of 10 cases. Quarterly J Medicine, New Series 1970; 39: 115-27.
5. Puthucheary SD, Lin HP, Yap PK. Acute septicaemic melioidosis. A report of seven cases. Trop Geogr Med 1981; 33: 19-22.
6. Tee KC, Chua CT, Lee MK, Puthucheary SD. Melioidosis, the great mimicker: A report of seven cases. J Trop Med Hyg 1988; 91: 249-54.
7. Puthucheary SD, Parasakthi N, Lee MK. Septicaemic melioidosis-a review of 50 cases from Malaysia. Trans Roy Soc Trop Med Hyg 1992; 86: 683-5. (Pubitemid 23012937)
8. Puthucheary SD, Yasmin A (eds). Melioidosis - Prevailing Problems and Future Directions. Selected papers from the 1st International Symposium on Melioidosis, Kuala Lumpur, April, 7-8, 1994. SP-Muda Printing Sdn. Bhd Kuala Lumpur.
9. Yabuuchi E, Kosako Y, Oyaiza H et al. Proposal of Burkholderia gen.nov, and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) Comb. nov. Microbiol Immunol 1992; 36: 1251-75.
10. White NJ. Melioidosis. Lancet 2003; 361: 1715-22.
11. Puthucheary SD, Vadivelu J. Human Melioidosis. Singapore University Press, 2002.
12. Puthucheary SD, Parasakthi N. Antimicrobial susceptibility of Pseudomonas pseudomallei. J Antimicrob Chemother 1987; 20: 921-2.
13. Karunakaran R, Puthucheary SD. Burkholderia pseudomallei: In vitro susceptibility to some new and old antimicrobials. Scandinavian J Infect Dis 2007; 39: 858-61.
14. Sam IC, See KH, Puthucheary SD. Varying ceftazidime and Amoxicillin- Clavulanate Susceptibilities within a clonal infection of Burkholderia pseudomallei. J Clin Microbiol 2009; 47: 1556-8.
15. Strauss JM, Groves MG, Mariappan M, Ellison DW. Melioidosis in Malaysia: II Distribution of Pseudomonas pseudomallei in soil and surface water. Am J Trop Med Hyg 1969; 18: 698-702.
16. Sam I-C, Puthucheary SD. Melioidosis and rainfall in Kuala Lumpur, Malaysia. J Infect 2007; 54: 519-20.
17. Puthucheary SD. Burkholderia pseudomallei and the Environment. In Furukawa H, Nishibuchi M, Kono Y, Kaida Y, (eds) Ecological Destruction, Health, and Development. Advancing Asian Paradigms. Kyoto, Kyoto University Press & Trans Pacific Press, 2004; 265-76.
18. Suputtamongkol Y, Hall AJ, Dance DAB, Chaowagul W, Rajchanuvong A, Smith MD, White NJ. The epidemiology of melioidosis in Ubon Ratchathani, northeast Thailand. Int J Epidemiol 1994; 23: 1082-90. (Pubitemid 24331225)
19. Anonymous. Melioidosis in Singapore. Epidemiol News Bulletin (Singapore) 1995; 21: 69-72.
20. How C, Sampath A. Spotnitz S. The pseudomallei group: a review. J Infect Dis 1971; 124: 598-619.
21. Pruekprasert P, Jitsurong S. Septicaemic melioidosis following near-drowning. Southeast Asian J Trop Med Publ Hlth 1991; 22: 276-8.
22. Schlech WF, Turchik JB, Westlake REJ, Klien CG, Band JD, Weaver RE. Laboratory acquired infection with Pseudomonas pseudomallei (melioidosis). N Engl J Med 1981; 305: 1133-5.
23. Currie B, Howard D, Nguyen VT, Withnall K, Merianos A. The 1990-1991 outbreak of melioidosis in the Northern Territory of Australia: clinical aspects. Southeast Asian J Trop Med Publ Hlth 1993; 24: 436-43.
24. Suputtamongkol Y, Chaowagul W, Chetchotisakd P et al. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis 1999; 29: 408-13.
25. Woods DE, Jones AL, Hill PJ. Interaction of insulin with Pseudomonas pseudomallei. Infect Immun 1993; 61: 1914-9.
26. Currie, BJ, Fischer DA, Howard DM et al. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Tropica 2000; 74: 121-7.
27. Chaowagul W, White NJ, Dance DAB et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 1989; 159: 890-9.
28. Walsh AL, Smith MD, Wuthiekanun V et al. Prognostic significance of quantitative bacteraemia in septicaemic melioidosis. Clin Infect Dis 1995; 21: 1498-500.
29. Tan APA, Pui MH, Tan LKA. "Imaging patterns in melioidosis. Aust Radiol 1995; 39: 260-4.
30. Steinmetz I, Stosiek P, Hergenrother D, Bar W. Melioidosis causing a mycotic aneurysm. Lancet 1996; 347: 1564-5.
31. Lee SST, Liu YC, Wang JH, Wann SR. Mycotic aneurysm due to Burkholderia pseudomallei.Clin Infect Dis 1998; 26: 1013-4.
32. Wong PK, Ng PH. Melioidosis presenting with orbital cellulitis. Singapore Med J 1966; 37: 220-1.
33. Puthucheary SD, Parasakthi N. The bacteriology of brain abscess: a local experience in Malaysia. Trans Roy Soc Trop Med Hyg 1990; 84: 589-92. (Pubitemid 20266992)
34. Ganesan D, Puthucheary SD, Waran V. Melioidosis presenting as spinal epidural abscess. Brit J Neurosurgery 2003; 17: 568-71.
35. Suputtamongkokl Y, Rajchanuwong A, Chaowagul W et al. Ceftazidime vs amoxycillin/clavulanic acid in the treatment of severe melioidosis. Clin Infect Dis 1994; 19: 846-53.
36. Puthucheary SD, Vadivelu J, Wong KT, Ong GSY. Acute respiratory failure in melioidosis. Singapore Med J 2001; 42: 117-21.
37. Currie BJ, Howard D, Nguyen VT, Withnall K, Merianos A. The 1990-1991 outbreak of melioidosis in the northern territory of Australia: clinical aspects. Southeast Asian J Trop Med Publ Hlth 1993; 24: 436-43.
38. Dhiensiri T, Puapairoj S, Susaengrat W. Pulmonary melioidosis: Clinical-radiologic correlation in 183 cases in Northeastern Thailand. Radiology 1988; 166: 711-5. (Pubitemid 18058929)
39. Weber DR, Douglas LE, Brendage WG, Stallkamp TC. Acute varieties of melioidosis occuring in U.S. soldiers in Vietnam. Am J Med 1969; 45: 234-44.
40. Vatcharapreechasakul T, Suputtamongkol Y, Dance DAB, Chaowagul W, White NJ. Pseudomonas pseudomallei liver abscesses: a clinical, laboratory and ultrasonographic study. Clin Infect Dis 1992; 14: 412-7.
41. Wong KT, Puthucheary SD, Vadivelu J. The histopathology of human melioidosis. Histopathology 1995; 26: 51-5.
42. Chaowagul W, Suputtamongkol Y, Dance DAB, Rajchanuvong A, Pattaraarechachai, White N J. Relapse in Melioidosis : Incidence and risk factors. J Infect Dis 1993; 168: 1181-5.
43. Nathan SA, Puthucheary SD. An electron microscopic study of the interaction of Burkholderia pseudomallei and human macrophages. Malaysian J Pathol 2005; 27: 3-7.
44. Vorachit M, Lam K, Jayanetra P, Costerton JW. Electron microscopic study of the mode of growth of Pseudomonas pseudomallei in vitro and in vivo. J Trop Med Hyg 1995; 98: 379-91.
45. Mohandas S, Puthucheary SD, Pang T. Relapsing infection due to Burkholderia pseudomallei detected by pulsed-field gel electrophoresis of sequential clinical isolates. Asia Pacific J Molec Biol Biotechnol 1995; 3: 224-9.
46. Vadivelu J, Puthucheary SD, Drasar BS, Dance DAB, Pitt TL. Stability of strain genotypes of Burkholderia pseudomallei from patients with single and recurrent episodes of melioidosis. Trop Med Int Hlth 1998; 3: 518-21.
47. Kopenen MA, Zlock D, Palmer DL, Merlin T L. Melioidosis. Forgotten, but not gone! Arch Int Med 1991; 151: 605-8.
48. Kanaphun P, Thirawattasuk N, Suputtamongkol Y et al. Serology and carriage of Pseudomanas pseudomallei: a prospective study in 1000 hospitalised children in Northeastern Thailand. J Infect Dis 1993; 167: 230-3.
49. Vadivelu J, Puthucheary SD, Gendeh GS, Parasakthi N. Serodiagnosis of melioidosis in Malaysia. Singapore Med J 1995; 36: 299-302.
50. Vadivelu J, Puthucheary SD. Diagnostic and prognostic value of an immunoflourescent assay for melioidosis. Am J Trop Med Hyg 2000; 62: 297-300.
51. Withiekanun V, Smith MD, White NJ. Survival of Burkholderia pseudomallei in the absence of nutrients. Trans R Soc Trop Med Hyg 1995; 89: 491.
52. Puthucheary SD, Vadivelu J, Ce-Cile C, Wong KT, Ismail G. Electron microscopic demonstration of extracellular structure of Burkholderia pseudomallei. Am J Trop Med Hyg 1996; 54: 313-4. (Pubitemid 26100723)
53. Nathan SA, Puthucheary SD. An electronmicroscopic study of the interaction of Burkholderia pseudomallei and human macrophages. Malaysian J Pathol 2005; 27: 3-7.
54. Puthucheary SD, Nathan SA. Comparison by electron microscopy of intracellular events and survival of Burkholderia pseudomalleiin monocytes from normal subjects and patients with melioidosis. Singapore Med J 2006; 47: 697-703.
55. Nathan SA, Quist R, Puthucheary SD. Kinetic studies of bioactive products nitric oxide and 8-iso-PGF2α in Burkholderia pseudomallei infected human macrophages, and their role in the intracellular survival of these organisms. FEMS Immunol Med Microbiol 2004; 43: 177-83.
56. Ismail G, Razak N, Mohamed R, Embi N, Omar O. Resistance of Pseudomonas pseudomallei to normal human serum bactericidal action. Microbiol Immunol 1988; 32: 645-52.
57. Chenthamarakshan V, Vadivelu J, Puthucheary SD. Detection of immunoglobulin M & G using a culture filtrate antigen of B urkholderia pseudomallei. Diagn Microbiol Infect Dis 2001; 39: 1-7. (Pubitemid 32149948)
58. Chenthamarakshan V, Kumutha MV, Vadivelu J, Puthucheary SD. Distribution of immunoglobulin classes and IgG subclasses against a culture filtrate antigen of Burkholderia pseudomalleiin melioidosis patients. J Med Microbiol 2001; 50: 55-61.
59. Vasu C, Vadivelu J, Puthucheary SD. The humoral immune response in melioidosis patients during therapy. Infection 2003; 31: 24-30.
60. Wong KT, Puthucheary SD, Vadivelu J. The histopathology of human melioidosis. Histopathology 1995; 26: 51-5.
61. White NJ, Dance DAB, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwathara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet 1982; 2: 697-701.
62. Sookpranee M, Boonma P, Susaengrat W, Bhuripanyo K. Punyagupta S. Multicentre prospective randomized trial comparing ceftazidime plus cotrimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis. Antimicrob Agents Chemother 1992; 36: 158-62.
63. Simpson AJH, Suputtamongkol Y, Smith MD et al. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis 1999; 29: 381-7. (Pubitemid 29380204)
64. Chaowagul W, Melioidosis; a treatment challenge. Scand J Infect Dis Suppl 1996; 101: 14-6.
65. Rajchanuvong A, Chaowagul W, Suputtamongkol Y, Smith MD, Dance DAB, White NJ. A prospective comparison of co-amoxyclav and the combination of chloramphenicol, doxycycline and co-trimoxazole for the oral maintenance treatment of melioidosis. Trans Roy Soc Trop Med Hyg 1995; 89: 546-9.
66. Suputtamongkol Y, Chaowagul W. Management and therapy of melioidosis in Puthucheary SD, Malik Y, (eds). Melioidosis: Prevailing Problems and Future Directions. 200-4. Selected papers from the First International Symposium on Melioidosis (Kuala Lumpur, Malaysian Society of Infectious Diseases and Chemotherapy, 1994).
67. Peacock SJ, Schweizer HP, Dance DAB et al. Management of accidental laboratory exposure to Burkholderia pseudomalleiand B. mallei. Emerg Infect Dis 2008 July; 14(7) e2. doi:10.320/eid 1407.071501.
68. Jeyaram M. Melioidosis- should it be a notifiable disease in Malaysia? Med J Malaysia 2005; 60: 531-4.